Tsc-36 (follistatin-related polypeptide) gene expression in estrogen receptor positive osteoblastic cell line, CDO7F

Calcified Tissue International

Volumn 61, Issue 5, 1997, Pages 400-403

  Ohashi, T ^a,b   Sato, S ^a   Yoshiki, A ^a   Kusakabe, M ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Estrogen receptor; Follistatin related polypeptide; Osteoblastic cell; TSC 36

Indexed keywords

ESTROGEN RECEPTOR; FOLLISTATIN; POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ESTROGEN ANTAGONISTS; ESTROGENS; FOLLISTATIN-RELATED PROTEINS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; MICE; OSTEOBLASTS; RECEPTORS, ESTROGEN; TAMOXIFEN; UP-REGULATION;

EID: 0030718532     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900355     Document Type: Article

References (28)

1. Lindsay R, Hart DM, Aitken JM, Anderson JB, MacDonald ER, Clark AC (1976) Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1:1038-1041
2. Barzel US (1988) Estrogens in the prevention and treatment of postmenopausal osteoporosis. Am J Med 85:847-850
3. Korach KS (1994) Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527
4. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
5. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR (1988) Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-84
6. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86
7. Ohashi T, Kusuhara S, Ishida K (1991) Estrogen target cells during the early stage of medullary bone osteogenesis: immunohistochemical detection of estrogen receptors in osteogenic cells of estrogen-treated male Japanese quail. Calcif Tissue Int 49:124-127
8. Ikegami A, Inoue S, Hosoi T, Mizuno Y, Nakamura T, Ouchi Y, Orimo H (1993) Immunohistochemical detection and northern blot analysis of estrogen receptor in osteoblastic cells. J Bone Miner Res 8:1103-1109
9. Somjen D, Weismann Y, Harell A, Berger E, Kaye AM (1989) Direct and sex-specific stimulation by sex steroids of creatin kinase activity and DNA synthesis in rat bone. Proc Natl Acad Sci USA 86:3361-3365
10. Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825-833
11. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC (1991) Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Endocrinology 129:3313-3320
12. Eielson C, Kaplan D, Mitnick MA, Paliwal I, Insogna K (1994) Estrogen modulates parathyroid hormone-induced fibronectin production in human and rat osteoblast-like cells. Endocrinology 135:1639-1644
13. Fukayama S, Tashjian AH (1989) Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 124:397-401
14. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC (1992) 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891
15. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91.
16. Ohashi T, Kusuhara S (1993) Immunoelectron microscopic detection of estrogen target cells in the bone marrow of estrogen-treated male Japanese quail. Bone Miner 20:31-39
17. Bellido T, Girasole G, Passeri G, Yu X-P, Mocharla H, Jilka RL, Notides A, Manolagas SC (1993) Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology 133:553-562
18. Chomczynsky P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
19. Hara E, Kato T, Nakada S, Sekiya S, Oda K (1991) Subtractive cDNA cloning using oligo(dT)30-latex and PCR: isolation of cDNA clones specific to undifferentiated human embryonal carcinoma cells. Nucleic Acids Res 19:7097-7104
20. Gray TK, Flynn TC, Gray KM, Nabell LM (1987) 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci USA 84:6267-6271
21. Chaudhary LR, Spelsberg TC, Riggs BL (1992) Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinology 130: 2528-2534
22. Keeting PE, Scott RE, Colvard DS, Han IK, Spelsberg TC, Riggs BL (1991) Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res 6:297-304
23. Colston KW, King RJB, Hayward J, Fraser DI, Horton MA, Stevenson JC, Arnett TR (1989) Estrogen receptors and human bone cells: immunocytochemical studies. J Bone Miner Res 4:625-631
24. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan C, Carbone PP, DeMets CL (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852-856
25. Turner RT, Wakley GK, Hannon KS, Bell NH (1987) Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Miner Res 2:449-456
26. Takeuchi M, Tokin M, Nagata K (1995) Tamoxifen directly stimulates the mineralization of human osteoblast-like osteosarcoma cells through a pathway independent of estrogen response element. Biochem Biophys Res Commun 210:295-301
27. 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem 217:13-19
28. 6 glioma-secreted follistatin-related protein (FRP), Cloning and sequence of the human homologue. Eur J Biochem 225:937-946